Latest Regulatory Milestones News

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Patrys Limited has expanded its therapeutic portfolio by acquiring Reliis Pty Ltd, adding a proprietary injectable asset targeting delirium with near-term clinical milestones. This strategic move complements its existing biologics platform and strengthens its financial position.

Nexsen Limited has reported significant progress in its rapid diagnostic technologies, including a key FDA pre-submission for its GBS rapid sensor and a solid cash reserve post-IPO to support commercialisation efforts.

European Metals Holdings has marked a pivotal quarter with the completion of a Definitive Feasibility Study for its Cinovec Lithium Project, securing a €360 million Czech government grant and submitting a key Environmental Impact Assessment, propelling the project closer to production.

Legacy Iron Ore Limited has completed phase I mining at its Mount Celia gold operation and made significant progress on the Mount Bevan magnetite project, underpinning its growth strategy in Western Australia’s mineral sector.

Richmond Vanadium Technology Ltd continues to push forward with its Richmond–Julia Creek Vanadium Project, progressing environmental approvals and technical collaborations despite subdued vanadium market conditions.

NuEnergy Gas Limited has completed drilling four wells at its Tanjung Enim project, gearing up for initial gas sales in the first half of FY26. The company also inked key agreements to finance and expand its coal bed methane operations in Indonesia.

Lumos Diagnostics reported a strong surge in FebriDx® sales alongside positive FDA feedback, securing full Medicare reimbursement and advancing key clinical studies.

Far East Gold’s December quarter report highlights significant high-grade gold discoveries at its Idenburg Project and a key regulatory approval that paves the way for accelerated development.

Syntara Limited has made significant strides in its clinical pipeline, launching new trials and receiving key regulatory designations, positioning 2026 as a pivotal year for the company.

Sinowin Lithium, MRG Metals’ joint venture partner, aims to kick off production at the massive Corridor Sands Heavy Mineral Sands Project in Mozambique by March 2027, backed by significant early investment and regulatory approvals.

Ark Mines has made significant strides in advancing its Sandy Mitchell Rare Earths Project, initiating a full-scale processing trial and securing critical environmental approvals, setting the stage for production by late 2027.